Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion

Laboratory Investigation

Volumn 86, Issue 9, 2006, Pages 951-958

  Guedj, Nathalie ^a   Dargere, Delphine ^a   Degos, Françoise ^b   Janneau, Jean Louis ^a   Vidaud, Dominique ^c   Belghiti, Jacques ^b   Bedossa, Pierre ^a,b   Paradis, Valerie ^a,b  

^a CNRS   (France)

^b BEAUJON HOSPITAL   (France)

^c UPRES EA 3618   (France)

Author keywords

Cirrhosis; Clonal analysis; Hepatocellular carcinoma; HUMARA; Proteomics

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; PROTEIN; PROTEOME;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MALIGNANT TRANSFORMATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEOMICS; SAMPLE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; X CHROMOSOME INACTIVATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; X CHROMOSOME INACTIVATION;

EID: 33747609082     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700450     Document Type: Article

References (33)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253-1257.
2. Hiroashi S, Ishak KG, Kojiro M, et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. IARC Press: Lyon, 2000, pp 159-172.
3. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346.
4. Aihara T, Noguchi S, Sasaki Y, et al. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroenterology 1994;107:1805-1811.
5. Ochiai T, Urata Y, Yamano T, et al. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma. Hepatology 2000;31:615-621.
6. Paradis V, Laurendeau I, Vidaud M, et al. Clonal analysis of macronodules in cirrhosis. Hepatology 1998;28:953-958.
7. Paradis V, Dargere D, Bonvoust F, et al. Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest 2000;80:1553-1559.
8. Aihara T, Noguchi S, Sasaki Y, et al. Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology 1996;111:455-461.
9. Yeh SH, Chen PJ, Shau WY, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001;121:699-709.
10. Colombat M, Paradis V, Bièche I, et al. Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. J Pathol 2003;201:260-267.
11. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-537.
12. Vlahou A, Schellhammer PF, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-1502.
13. Petricoin EF, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-1578.
14. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002;48:1835-1843.
15. Cazares LH, Adam BL, Ward MD, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002;8:2541-2552.
16. Zhang Z, Bast RC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-5890.
17. Paradis V, Degos F, Dargere D, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005;41:40-47.
18. Zhang SH, Cong WM, Wu MC. Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis. J Clin Pathol. 2004;57:556-559.
19. Tang LH, Hui P, Garcia-Tsao G, et al. Multiple angiomyolipomata of the liver: a case report. Mod Pathol 2002;15:167-171.
20. Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148:1089-1096.
21. Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356:1749-1756.
22. Wulfkuhle JD, Paweletz CP, Steeg PS, et al. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol 2003;532:59-68.
23. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003;3:267-275.
24. Yokoyama Y, Kuramitsu Y, Takashima M, et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004;4:2111-2116.
25. Zeindl-Eberhart E, Haraida S, Liebmann S, et al. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 2004;39:540-549.
26. Park KS, Cho SY, Kim H, et al. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 2002;97:261-265.
27. Yoon GS, Lee H, Jung Y, et al. Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 2000;60:1117-1720.
28. Issaq HJ, Veenstra TD, Conrads TP, et al. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 2002;292:587-592.
29. Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004;15:24-30.
30. Petricoin EF, Ornstein DK, Liotta LA. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol Oncol 2004;22:322-328.
31. Li C, Hong Y, Tan YX, et al. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with ' and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics 2004;3:399-409.
32. Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005;42:809-818.
33. Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002;6:497-512.